// App-Quantinova.ai

: A FVIII-Mimetic Bispecific Antibody with an Embedded Self-Regulation Mechanism Reduces the Risk of Prothrombotic Events for the Treatment of Haemophilia a

Researchers

Presenter

  • Vincent Muczynski

Principal Investigators

  • Angel Smith

  • Thibaud Sefiane

  • Olivier D. Christophe

  • Peter J. Lenting

  • David Granger

  • Kerry Chester

  • Amit C. Nathwani

Medical Centers

  • Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free NHS Foundation Trust, London, United Kingdom

  • University College London - Cancer Institute, London, United Kingdom

  • Inserm U, Le Kremlin-Bicetre, France

Locations

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Evithrom

  • FVIII

Outcome

  • N/A

Study Design

  • Safety

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved